The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/il-6-vaccine-shows-early-benefit-knee-osteoarthritis-2025a1000yhv?src=rss
Author :
Publish date : 2025-12-09 12:30:00
Copyright for syndicated content belongs to the linked Source.